Venous Leg Ulcers: EscharEx Treatment Study

We are studying whether EscharEx can help improve wound healing in people with Venous Leg Ulcers compared to a placebo. This trial aims to assess its safety and effectiveness in wound care.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Concentrate Of Proteolytic Enzymes Enriched In Bromelain
A pineapple-derived enzyme concentrate that helps reduce inflammation and swelling and may aid digestion.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Amnion/Chorion Membrane Allograft
EscharEx

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Medical University of Graz
Division of Plastic, Aesthetic and Reconstructive Surgery
Graz, Austria
Noe LGA Gesundheit Region Mitte GmbH
Clinical Department for Plastic, Aesthetic and Reconstructive Surgery
Sankt Pölten, Austria
Medical University of Vienna
Dept. of Plastic, Reconstructive & Aesthetic Surgery
Vienna, Austria

Sponsor: Mediwound Ltd.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.